NHS cancer services not holding up, says report
September 8, 2014Research and Development, Sales and Marketing CRUK, Cancer, NHS, UK, government, oncology
NHS cancer services are in urgent need of investment and review, according to a new report commissioned by Cancer Research …
Servier slammed over UK trial transparency failure
September 8, 2014Medical Communications, Research and Development, Sales and Marketing ABPI, PMCPA, Servier, code, conduct, transparancy, trials
Servier has been found guilty of the most serious breach of the UK’s pharma code of conduct after failing to …
BMS sues Merck over new melanoma drug
September 8, 2014Research and Development, Sales and Marketing BMS, FDA, Merck, PD-1 inhibitors, Yervoy, keytruda
Things are getting ugly between Bristol-Myers Squibb and Merck as the former company began legal proceedings against the latter over …
MHRA leads social media drug safety initiative
September 8, 2014Medical Communications, Sales and Marketing EFPIA, EU, MHRA, social media, web-radr
The MHRA has announced that it is to lead European medicines regulators, academics and pharma in a three-year project to …
Bristol-Myers Squibb: following the string of pearls
September 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, BMS, GSK, Johanna Mercier, Pfizer, UCB, Yervoy, acquisitions
Bristol-Myers Squibb (BMS) is something of an enigma in the pharma industry. Whilst many of its big pharma peers are …
Theraclion hires chief executive and VP
September 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Anja Kleber, David Caumartin, Theraclion
French medical device firm Theraclion has appointed David Caumartin as its chief executive and Anja Kleber as vice president of …
Sanofi releases new diabetes app for children
September 5, 2014Medical Communications, Sales and Marketing Gamification, Lilly board game, Sanofi, Syrum, monster manor
Sanofi Diabetes has launched a new mobile game aimed at educating children, teachers, parents and carers about living with type …
Remembering the patient in the Cancer Drugs Fund debate
September 5, 2014Medical Communications, Sales and Marketing Beating Bowel Cancer, Cancer Drugs Fund, Kadclya, Roche
Today Simon is a bowel cancer patient who is able to enjoy his weekly round of golf.After receiving the dreadful …
Edelman buys Elan to ‘challenge’ the French PR industry
September 5, 2014Medical Communications, Sales and Marketing Edelman, Elan, publicis
Edelman has swooped in on fellow PR firm Elan to create a ‘new player’ in the communications industry in France. …
NHS spends over £1 million on Apple products
September 5, 2014Medical Communications, Sales and Marketing Apple, NHS England, ipad, iphone
NHS England has spent more than £1.2 million on Apple’s tablets and smartphones since it was set up two years’ …
Merck surprise winner in PD-1 race
September 5, 2014Medical Communications, Research and Development, Sales and Marketing Cancer, Merck, melanoma, pd-1
Merck has become the first company to bring a new class of cancer drug to the US market after the …
J&J fast-track Ebola vaccine for early 2015 trials
September 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Africa, Ebola, Mapp, zmapp
Johnson & Johnson has announced it is to fast-track the development of a new vaccine programme to fight the deadly …
Teva launches new MS eHealth site
September 4, 2014Medical Communications, Sales and Marketing Teva, digital, ms ireland, multiple sclerosis, pow health
Teva and MS Ireland have helped launch a new website called Pow Health to give multiple sclerosis patients a “one-stop …
AbbVie and Infinity sign cancer deal
September 4, 2014Research and Development, Sales and Marketing AbbVie, IPI-145, blood cancer, duvelisib, infinity
AbbVie has partnered with US company Infinity Pharmaceuticals to develop and commercialise the latter firm’s blood cancer treatment duvelisib (IPI-145). …
New chief executive for Healthcare Communications Association
September 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Anneliese Cameron, HCA, Healthcare Communications Association, julia cook
The Healthcare Communications Association (HCA) has a new chief executive in Anneliese Cameron who replaces Julia Cook next year in …
Google partners with AbbVie on ageing
September 4, 2014Medical Communications, Research and Development, Sales and Marketing 23andME, AbbVie, Abbott, Roche, calico, google
Google’s healthcare company Calico has signed its first pharma pact with US firm AbbVie in a deal that could be …
ICON appoints vice president from Allergan
September 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ICON, ira spector
Healthcare outsourced development firm ICON has hired Dr Ira Spector to be the executive vice president of its analytics and …
NICE backs world’s most expensive medicine
September 4, 2014Sales and Marketing AGNSS, Alexion, England, NICE, aHUS, solaris
In a U-turn on its previous guidance NICE is now recommending that the £330,000 rare disease drug Soliris should be …
Mixed results for AZ’s troubled Brilinta
September 3, 2014Sales and Marketing AstraZeneca, Brilinta, EMA, PCI, atlantic, heart, stent
The latest trial for AstraZeneca’s heart drug Brilinta (ticagrelor) has failed to meet expected results but suggests more flexible applications …
Should patients be able to email their general practitioner?
September 3, 2014Medical Communications, Sales and Marketing BMJ, GPs, clinicians, econsultations, email
Email consultations with your doctor make better use of their time and are more convenient, or threaten safety and create …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
